Objective: The objective of the study is to evaluate utilization patterns of drugs in patients suffering from Gastro-intestinal (G.I.) cancer at a tertiary care teaching hospital. Materials and Methods: This prospective, observational study was carried out at the Department of Pharmacology and Oncology, GCS Medical College, Hospital and Research Centre, Ahmedabad, to assess the drug utilization pattern in patients of cancer. The study was carried out over a period of 19 months from August 2019 to March 2021. A total of 43 patients were enrolled for the study. Patient’s demographic, clinical, and therapeutic data were collected from the files and in person ward visit and analyzed in Microsoft Excel version 2015. Results: Diagnosis of G.I carcinoma was highest in age group of >60 years (44.19 %). Colon (23.26%) was commonest organ affected followed by esophagus (16.28%) and stomach (11.63%) subsequently. Family history of cancer was seen in 25.6% patients, while 51.2% gave history of Tobacco consumption. Oxaliplatin and CAP: Capecitabine (OXA + CAP) was the most commonly used initial combination followed by CAR: Carboplatin and PAC: Paclitaxel (PAC + CAR).

Objective: The objective of the study is to evaluate utilization patterns of drugs in patients suffering from Gastro-intestinal (G.I.) cancer at a tertiary care teaching hospital. Materials and Methods: This prospective, observational study was carried out at the Department of Pharmacology and Oncology, GCS Medical College, Hospital and Research Centre, Ahmedabad, to assess the drug utilization pattern in patients of cancer. The study was carried out over a period of 19 months from August 2019 to March 2021. A total of 43 patients were enrolled for the study. Patient’s demographic, clinical, and therapeutic data were collected from the files and in person ward visit and analyzed in Microsoft Excel version 2015. Results: Diagnosis of G.I carcinoma was highest in age group of >60 years (44.19 %). Colon (23.26%) was commonest organ affected followed by esophagus (16.28%) and stomach (11.63%) subsequently. Family history of cancer was seen in 25.6% patients, while 51.2% gave history of Tobacco consumption. Oxaliplatin and CAP: Capecitabine (OXA + CAP) was the most commonly used initial combination followed by CAR: Carboplatin and PAC: Paclitaxel (PAC + CAR).